Final Exam Quizlet Flashcards
hypovolemia
loss of water AND electrolytes
hypovolemia defining characteristics
confusion, combative, coma
tachycardia/pnea
irritable
dizzy, weak, fever
orthostatic hypotension
increased hct, BUN, and Na+
decreased hgb
hypovolemia interventions and assessments
monitor Na+, urine specific gravity, osmolality, vitals, I&Os, abd girth, daily weight
salt free foods
IV fluids
replace lost fluids over 48h
skin care and O2
hypervolemia
sodium and water retention
defining characteristics of hypervolemia
confusion, disoriented, convulsion, coma
increased BP
decreased BUN, hct, sodium, specific gravity
SOB, tachypnea, dyspnea, weak, crackles, pleural effusion, pulmonary edema, peripheral edema, ascites, polyuria, weight gain
hypervolemia interventions and assessments
monitor ABG, resp status, response to diuretics, rate of IV therapy, abd girth for ascites, strict I&Os, weight
restrict sodium and fluid intake, administer diuretics as prescribed, O2 therapy, elevate HOB
hypervolemia interventions and assessments
monitor ABG, resp status, response to diuretics, rate of IV therapy, abd girth for ascites, strict I&Os, weight
restrict sodium and fluid intake, administer diuretics as prescribed, O2 therapy, elevate HOB
resp acidosis risk factors
hypoventilation (COPD, PNA, atelectasis)
resp depression (barb or sedative, Guillain-barre)
resp arrest
resp acidosis clinical manifestations
neurological (coma, drowsy, disoriented)
cardio (hypotension, tachy)
resp (shallow, dyspnea, tachy, brady)
muscular (weak, tremors)
GI (N/V/D)
resp alkalosis risk factors
hyperventilation, anxiety, salicylates, disease states, mechanical overventilation, hypermetabolic states, acute hypoxia, pulmonary disease, anemia, hypotension
resp alkalosis clinical manifestations
neurologic: hyporeflexia, disoriented, weak, coma
muscular: tetany, hyperreflexia
respiratory: hyperventilation, dyspnea, tachypnea
cardiac: syncope, chest pain, EKG changes
diaphoresis
metabolic acidosis risk factors
cardiac arrest, ASA overdose, excess production of acids (DKA, lactic)
inadequate loss of acids (uremia)
excess loss of base (diarrhea)
metabolic acidosis clinical manifestations
neurologic: hyporeflexia, disoriented, weak, coma
GI: n/v/d, abdominal pain, dehydration
Cardiac: peripheral edema, weak pulse, hypotension
respiratory: hyperventilation
metabolic acidosis nursing interventions
treat underlying cause (diarrhea, DKA)
monitor K+ levels, neurologic status
provide mechanical ventilation
dialysis as ordered
metabolic alkalosis risk factors
loss of acids (vomit, excess gastric suctioning)
base or buffer imbalance (K+ deficit, excess NaHCO3 intake)
disease states (cushings, kidney)
multiple transfusions
over correction of acidosis
metabolic alkalosis clinical manifestations
neurologic: confusion, stupor, coma
GI: anorexia, nausea, vomiting
MS: weakness, tetany, paresthesia
hyperreflexia, tremors, cramps
respiratory: hypoventilation, cyanosis
potassium important info
NEVER IM OR IV PUSH/BOLUS
never on empty stomach
diuretics cause what
K+/Na+ loss
5 pain stimulating substances
histamine
bradykinin
acetylcholine
potassium
prostaglandins
3 pain controlling substances
enkephalins, endorphins, serotonin
acute pain
SYMPATHETIC nervous system responses
related to specific injury
protective pain
pt restless, anxious
goes away within 3 months
distinct starting point and cause
chronic pain
PARASYMPATHETIC
adaptation response
6 months+
chronic pain treatment
decrease time loss from work
increase quality of relationships
decrease anxiety
superficial pain
in cutaneous area
mild to moderate pain with sympathetic manifestations (rapid, shallow, respirations)
deep somatic pain
felt below the cutaneous area
both sympathetic and parasympathetic
ex. tendons, ligaments, bones, blood vessels, nerves
visceral pain
can have superficial or deep somatic pain that localized
confined to a specific area
referred pain
felt in a part of the body other than where the pain was produced
a type of visceral pain
usually originates in one organ but felt in the skin
intractable pain
severe pain
resistant to treatment and any of the usual relief measures
pt usually referred to neurologist
breakthrough pain
acute exacerbation of pain that is transitory
ex. pt given q4 hours but experiences pain in between the doses
still must be treated
cancer-related pain
progression of cancer
can be caused by treatment
acute or chronic
large dose of pain meds
not PRN, around the clock
adaption response
vitals are normal, no symptoms
only discuss pain if asked
sleepiness, shifting away or guarding, facial expressions, withdrawing from socialization
NSAIDS do what
block prostaglandins in PERIPHERY
acetaminophen does what
blocks prostaglandins in CNS
analgesic adjuvants
anticonvulsants and anti anxiety
pain management WHO ladder
mild-moderate: nonopioids like ASA, NSAIDS, paracetamol
mod-severe: mild opioids (codeine), with or without nonopioids
severe: strong opioids (morphine) with or without non opioids
pain meds effective within how long
30-60 min
elderly nursing responsibilities (drugs)
more sensitive
monitor opioid doses, titrate down
reduced sensory perception and metabolism
PCA
Patient is getting a continuous dose every hour, but is allowed to get a bolus infusion every 15 minutes if they need more relief.
- Used for cancer pain and post op pain
-Morphine/ Hydromorphone
cancer treatment considerations
biopsy
neutropenic precautions
hospice
chemo
internal radiation
chemo
3 kinds of biopsy
excision
incision (large tumor where part are removed for analysis)
needle biopsy (tissue samples from mass are aspirated)
neutropenic precautions
no flowers/fresh fruit/raw veggies
wear mask, gown, gloves
avoid crowds
keep door closed
disposable equipment used
hospice
6 months or less to live
chemo
systemic intervention
antineoplastics (kills cancer cells)
Primary, adjuvant, or neoadjuvant
Given VAD (larger veins in chest, implanted in chest, dressing changed every 48 hours), or a PICC
MONITOR NEUTROPHILS
chemo side effects
finger numbness, bone marrow suppression (MONITOR FOR 100 DAYS), n/v, anorexia, GI disturbance, alopecia, mucositis (culture lesions), stomatitis, loss of libido, impotence
internal radiation
brachytherapy
sealed/unsealed source
radioactive device in patient
brachytherapy
device in pt so radiation is in continuous contact with tumor
pt is radioactive while device is in them
strict bedrest with bathroom privileges, low residue diet, antidiarrheals, urinary catheter
internal radiation safety standards
distance, time, shielding
avoid handling if dislodged
6 feet away at all times except essential care
30 min/8 hours
give meds at same time as assessments
pt alone in room
internal radiation systemic side effects
nausea, fatigue, myelosuppression (thrombocytopenia, leukopenia, anemia)
internal radiation localized effects
stomatitis, dysgeusia (altered taste sensation), xerostomia (dry mouth)
cancer excision surgery
tumor is small and excised
removed entirely and sent to lab for examination
paliative surgery
done when cure is not possible to improve quality of life
microcytic anemia
iron deficiency
megaloblastic anemia
folic deficiency
pernicious anemia
B12 deficiency
hypoproliferative anemia
underproduction of RBCs by bone marrow
hemolytic anemia
increased destruction of RBCs
RES destroys RBCs
hgb levels and clini manifestations
mild: 10-12
asymptomatic, fatigue
moderate: 6-10
fatigue, dyspnea, palpitations, tachy, diaphoresis on exertion
severe: below 6
chronic fatigue, severe symptoms, peripheral edema
anemia diagnostics
history and physical CBC
reticulocyte count
coag screening (INR, PT, PTT)
bone marrow aspiration
INR/PT
warfarin
PTT
heparin
iron deficiency anemia (microcytic) risk factors
blood loss
hemorrhoids
menstruating and pregnant
adolescents, children, infants
microcytic anemia nursing care
diet rich in eggs, meat, leafy greens, liver (best source), vit C
minimal milk, fiber, soy, coffee, tea
supplemental iron (rinse, straws)
Z track injections
monitor for dark tarry stools (can indicate internal bleeding)
avoid antacids
folate deficiency anemia risk factors
does not affect nervous system
alcohol
seizure meds
genetics (crohns, celiac)
infants
megaloblastic anemia treatment
oral/dietary supplements (folic acid from diet, vit B12)
treat underlying condition
decrease alcohol
S&S of megaloblastic anemia
decreased appetite
irritable, fatigue, diarrhea, glossitis, pallor
B12 deficiency (pernicious anemia) diet
meat, fish, fortified cereal, tofu
pernicious anemia risk factors
decreased b12/malabsorption
ileal resection
crohn’s disease
gastrectomy
hereditary lack of intrinsic factor
vegans
autoimmune
anything harming gastric lining
pernicious anemia symptoms
slow onset
decreased mental status (peripheral neuropathy)
glossitis (beefy red tongue)
mood swings
decreased CO
decreased RBC, hgb. hct
vitiligo and greying hair
pernicious anemia diagnosis
schilling test
PO administration
small dose of radioactive vit B12
if urine is radioactive, it means they have enough B12 so it’s being excreted, which is good
pernicious anemia management
Vit B12 injections
never orally if caused by gastrectomy
cyanocobalamin (IM or nasal spray), monthly, response within 24-48 hr, within 72 hr RBC and reticulocyte count increases
iron supplements
o2 administration
blood transfusions
erythropoietin injections twice a week until iron stores are replenished
aplastic anemia
normocytic and normochromic erythrocytes (normal size and heme content, low in number)
bone marrow hypoplasia: incomplete RBC development
bone marrow aplasia: lack of RBC development
pancytopenia: BM suppression, decreased RBC, WBC, PLT
aplastic anemia risk factors
congenital
idiopathic
idiosyncratic (drug reaction)
acquired (myelotoxins)
autoimmune infections: epstein barr
aplastic anemia causes
altered stem cell: inhibits division
altered BM (replaced by fat)
aplastic anemia S&S
pancytopenia
petechia (low PLT)
purple/red spots
purpura (bleeding under skin)
retinal hemorrhage
hypoxia
anemia S&S
aplastic anemia care
immediate withdrawal of offending agent
transfusions
radiotherapy
bone marrow transplant
bone marrow aspiration/biopsy
TB
reportable, communicable, inflammatory, destructive disease
spread from person to person via inhalation of infected droplet nuclei
TB risk factors
homeless, malnutrition, overcrowded areas, health care workers, immune dysfunction, alcoholism, children under 3, elderly, certain geographic areas, men double the rate of women
TB microorganism characteristics
aerobic
acid fast
reproduces slowly in the body
destroyed by heat, sun, and pasteurization
TB sensitization
1st time individual is infected= develops a sensitivity reaction
occurs 2-10 weeks after primary infection
positive reaction to tuberculin skin tests
TB infected individuals
residual remains dormant in lungs
asymptomatic
partial destruction of most organisms can occur
may reactivate later when resistance is decreased
can be triggered by mental and physical stress, oncology, inadequate drug treatment
TB skin test
people with HIV may get false negative, contraindicated in BCG vaccine patients
reliable
appearance of a “wheal”, induration area read within 48-72 hours
10mm or more is positive reaction
TB converters
someone who develops a positive skin test, negative test converted to positive
high risk for developing TB
placed on INH preventative therapy for 6-12 months
quantiFERON-TB gold test
preferred to those with BCG
results in 24-36 hours
negative test means no latent or active TB
TB sputum culture
confirms diagnosis
3 specimen on consecutive days
negative TB test
no longer contagious
contagious until treated
TB patient room
isolated
negative pressure until negative sputum culture
wear mask for 3 weeks
TB management
treatment for 6-12 months
primary resistance TB
one or more line of anti TB agents
secondary (acquired) resistance
resistance to one or more anti TB agents and undergoing therapy
multi-drug resistance TB
resistance to 2+ agents like INH and rifampin
first line TB drugs
INH and rifampin
pyrazinamide (PZA, for active TB)
ethambutol (myambutol)
TB interventions
teach regimen and side effects, importance of compliance
prevention of spread
what to avoid with INH
high protein, high calorie, high calcium diet with iron and B6 supplements
5 foods to avoid with INH
tuna, red wine, aged cheese, soy sauce, yeast extract
asthma incidence, etiology, risks
allergy, esophageal reflux, male, genetics, elderly, urban areas, ethnicity
asthma clinical manifestations
wheezing, chest tightness, dyspnea, SOB, no wheezing if blocked, cough, tachycardia, diaphoresis, anxiety, panic, mood changes, hyperventilation
bronchodilators
increases smooth muscle relaxation
no effect on inflammation
increase fluid intake
take 5 min before other inhaled drugs
monitor HR
methylxanthines
long acting
theophylline
dilates bronchi, used when other drugs ineffective
can build up and become toxic
cholinergic agonists
intermediate acting
ipratropium
watch for increased HR
anti inflammatory drugs asthma
corticosteroids
long acting, local or systemic
pulmicort/flovent/azmacort= most common
significant S/E= delayed wound healing, personality changes, fluid retention, taper doses, rinse mouth
asthma complications
pneumonia, atelectasis, hypoxemia, respiratory acidosis, respiratory failure, emphysema, chronic hypoxia, chronic bronchitis, asthmaticus
COPD
emphysema and chronic bronchitis
symptoms of COPD
worsening breathlessness upon exertion, leads to breathlessness at rest